BEIJING, Aug. 31, 2011 /PRNewswire-Asia-FirstCall/ — Concord
Medical Services Holdings Limited (“Concord Medical” or the
“Company”, NYSE:
CCM), the operator of the largest network of radiotherapy and
diagnostic imaging centers in China, today announced that the
Company has appointed Mr. Adam Jigang Sun as Acting Chief Financial
Officer, effective on September 1, 2011. Mr. Adam Sun will replace
the current Chief Financial Officer, Mr. Steve Sun, who will
continue to serve as Co-chairman of the Board of Directors.
Mr. Steve Sun will focus on leading Concord Medical’s network
expansion and strategic acquisitions in addition to other duties as
a member of the Board.
Mr. Adam Sun will oversee the Company’s finance and reporting
functions, as well as assist Mr. Steve Sun in managing the
Company’s network expansion and strategic acquisitions. Mr. Adam
Sun and Mr. Steve Sun are not related.
Mr. Adam Sun has more than 10 years of experience in finance and
management. From January 2011 to August 2011, Mr. Adam Sun served
as the CFO of a subsidiary of Asia Pacific Medical Group, a
privately-held health management company based in Beijing, where he
participated in the acquisition of a private hospital in Beijing.
From June 2010 to December 2010, Mr. Sun was the Vice President of
Corporate Development of China Ritar Power Corp., a publicly traded
battery manufacturer, where he was responsible for corporate
planning, acquisitions, and investor relations. From December 2008
to June 2010, Mr. Sun served as the CFO of Shijiazhuang Gongda
Chemical Engineering Equipment Co., Ltd. (“Gongda”), a Chinese
supplier of process-engineering equipment and solutions. His CFO
duties at Gongda included helping complete a private equity
financing by strategic investors. From 2004 to 2008, Mr. Sun
co-founded and led a financial advisory firm, IA Exchange, Inc.,
that specialized in pro
‘/>”/>
